see below

/in /by

Home>Homework Answsers>Nursing homework helpnursingnursing researchMM3rd emaila year ago25.03.202410Report issuefiles (1)Diabetes_discussion.docx1.pdfDiabetes_discussion.docx1.pdfYou are seeing a 64-year-old Hispanic male for his diabetes management. He reports that his morningcapillary blood sugar readings are ranging in the 150 to 190 range.Last month his Hgb A1C was 7.4He is on Metformin 1000mg twice a day and Glipizide 5mg daily.He walks a couple miles three to five times a week.A dietary review reveals that his daily total carbohydrate intake is in the range of 75 to 100 grams.Last eye exam did not reveal any problems. He wears reading glasses when needed.He does report some intermittent burning sensation in his feet.Ht 6’2”, Wt 200 lbs, BP 118/72, P 72, R 17Heart regular rhythm, without murmur or gallopLungs clearMonifilament testing does not reveal any decreased sensation in the feetSubjective (S): The patient is a 64-year-old Hispanic male. He has come in for a scheduled office visit forhis diabetes medication management. The patient takes medications daily, but blood glucose levels inthe mornings are in the range of 150-190. The patient leads an active lifestyle and walks a couple ofmiles 3 to 5 days per week. The patient reports that he maintains his carbohydrate intake between 75 to100 grams per day. The patient takes 1000 mg of Metformin twice daily and 5 mg of Glipizide once daily.The patient states this his last eye exam was routine, and he wears reading glasses when needed.Patient reports some intermittent burning sensations in his feet.(O): Hgb A1C 7.4 a month ago. Ht. 6’2”. Wt. 200 pounds. BP 118/72. Pulse 72. RR 17. Lungs clear.Heart rhythm regular, no murmur or gallop noted. Monifilament testing does not reveal any decreasedsensations in his feet.(A): Based on the patients’ morning blood sugars, his diabetes is not well managed due to his elevatedA1C and blood sugar levels. Based on the patients’ symptoms of burning sensations that he has diabeticneuropathy.(P): Therapeutics: Based on the patient’s lab results, his current medication regimen is not regulating hisblood glucose levels. The lowest dose of Metformin is 500 mg once or twice daily and the maximumdose is 2550 mg (Arcangelo et al., 2017). The evening dose of Metformin will be increased to 1500 mg.Patient will continue to self-monitor blood glucose in the morning. Patient will maintain a food diary foreach meal until the follow-up appointment. Hgb A1C will be rechecked in 3 months. Although the HgbA1C goal for most patients is generally less than 7% per ADA guidelines, a more stringent goal of 6.5%may be established for some patients if there is no significant hypoglycemia or adverse effects (Woo &Robinson, 2016). Neuropathic pain conditions do not react to analgesic medications since peripheral andThis study source was downloaded by 100000760925736 from CourseHero.com on 03-24-2024 17:51:52 GMT -05:00https://www.coursehero.com/file/90074009/Diabetes-discussiondocx/https://www.coursehero.com/file/90074009/Diabetes-discussiondocx/central triggers cause it. (Arcangelo et al., 2017). Gabapentin or pregabalin can be useful in controllingthe discomfort from neuropathy. (Arcangelo et al., 2017). Patient education will focus on understandingthe pathophysiology of diabetes and prevention of complications, and the role of lifestyle modification.Consultation: Patient will be referred to a diabetes self-management education (DSME) program.Follow-up with patient in 2 weeks to review blood glucose and food diaries. Hgb A1C recheck in 3months. If the hgb A1C is still elevated, then practitioner will start patient on long-acting orintermediate-acting insulin. Initial dose of LAI or IAI is administered in a single dose at bedtime or in themorning; the typical starting does is 6 to 10 units or 0.1 to 0.2 units/kg of body weight/d (Woo &Robinson, 2016).ReferencesArcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (2017). Pharmacotherapeutics for advancedpractice: A practical approach (4th ed.). Wolters Kluwer.Woo, T. M., & Robinson, M. V. (2016). Pharmacotherapeutics for advanced practice nurse prescribers(4th ed.). F. A. Davis.This study source was downloaded by 100000760925736 from CourseHero.com on 03-24-2024 17:51:52 GMT -05:00https://www.coursehero.com/file/90074009/Diabetes-discussiondocx/
Powered by TCPDF (www.tcpdf.org)https://www.coursehero.com/file/90074009/Diabetes-discussiondocx/http://www.tcpdf.orgDiabetes_discussion.docx1.pdfYou are seeing a 64-year-old Hispanic male for his diabetes management. He reports that his morningcapillary blood sugar readings are ranging in the 150 to 190 range.Last month his Hgb A1C was 7.4He is on Metformin 1000mg twice a day and Glipizide 5mg daily.He walks a couple miles three to five times a week.A dietary review reveals that his daily total carbohydrate intake is in the range of 75 to 100 grams.Last eye exam did not reveal any problems. He wears reading glasses when needed.He does report some intermittent burning sensation in his feet.Ht 6’2”, Wt 200 lbs, BP 118/72, P 72, R 17Heart regular rhythm, without murmur or gallopLungs clearMonifilament testing does not reveal any decreased sensation in the feetSubjective (S): The patient is a 64-year-old Hispanic male. He has come in for a scheduled office visit forhis diabetes medication management. The patient takes medications daily, but blood glucose levels inthe mornings are in the range of 150-190. The patient leads an active lifestyle and walks a couple ofmiles 3 to 5 days per week. The patient reports that he maintains his carbohydrate intake between 75 to100 grams per day. The patient takes 1000 mg of Metformin twice daily and 5 mg of Glipizide once daily.The patient states this his last eye exam was routine, and he wears reading glasses when needed.Patient reports some intermittent burning sensations in his feet.(O): Hgb A1C 7.4 a month ago. Ht. 6’2”. Wt. 200 pounds. BP 118/72. Pulse 72. RR 17. Lungs clear.Heart rhythm regular, no murmur or gallop noted. Monifilament testing does not reveal any decreasedsensations in his feet.(A): Based on the patients’ morning blood sugars, his diabetes is not well managed due to his elevatedA1C and blood sugar levels. Based on the patients’ symptoms of burning sensations that he has diabeticneuropathy.(P): Therapeutics: Based on the patient’s lab results, his current medication regimen is not regulating hisblood glucose levels. The lowest dose of Metformin is 500 mg once or twice daily and the maximumdose is 2550 mg (Arcangelo et al., 2017). The evening dose of Metformin will be increased to 1500 mg.Patient will continue to self-monitor blood glucose in the morning. Patient will maintain a food diary foreach meal until the follow-up appointment. Hgb A1C will be rechecked in 3 months. Although the HgbA1C goal for most patients is generally less than 7% per ADA guidelines, a more stringent goal of 6.5%may be established for some patients if there is no significant hypoglycemia or adverse effects (Woo &Robinson, 2016). Neuropathic pain conditions do not react to analgesic medications since peripheral andThis study source was downloaded by 100000760925736 from CourseHero.com on 03-24-2024 17:51:52 GMT -05:00https://www.coursehero.com/file/90074009/Diabetes-discussiondocx/https://www.coursehero.com/file/90074009/Diabetes-discussiondocx/central triggers cause it. (Arcangelo et al., 2017). Gabapentin or pregabalin can be useful in controllingthe discomfort from neuropathy. (Arcangelo et al., 2017). Patient education will focus on understandingthe pathophysiology of diabetes and prevention of complications, and the role of lifestyle modification.Consultation: Patient will be referred to a diabetes self-management education (DSME) program.Follow-up with patient in 2 weeks to review blood glucose and food diaries. Hgb A1C recheck in 3months. If the hgb A1C is still elevated, then practitioner will start patient on long-acting orintermediate-acting insulin. Initial dose of LAI or IAI is administered in a single dose at bedtime or in themorning; the typical starting does is 6 to 10 units or 0.1 to 0.2 units/kg of body weight/d (Woo &Robinson, 2016).ReferencesArcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (2017). Pharmacotherapeutics for advancedpractice: A practical approach (4th ed.). Wolters Kluwer.Woo, T. M., & Robinson, M. V. (2016). Pharmacotherapeutics for advanced practice nurse prescribers(4th ed.). F. A. Davis.This study source was downloaded by 100000760925736 from CourseHero.com on 03-24-2024 17:51:52 GMT -05:00https://www.coursehero.com/file/90074009/Diabetes-discussiondocx/
Powered by TCPDF (www.tcpdf.org)https://www.coursehero.com/file/90074009/Diabetes-discussiondocx/http://www.tcpdf.orgBids(50)Dr. Ellen RMDr. Aylin JMPROF_ALISTERSheryl HoganProf Double REmily ClareDr. Sarah BlakeProWritingGurufirstclass tutorFiona DavaMUSYOKIONES A+Dr CloverDiscount AssigngrA+de plusJahky BDr. Everleigh_JKColeen AndersonIsabella HarvardBrilliant GeekTutor Cyrus KenShow All Bidsother Questions(10)Ford Motor Company SWOT Analysis: Strengths (internal to organization) Weaknesses (internal to organization) Opportunities (external environment) Threats (external environment) What do you think their current positioning is ? What do you think their mACC 206 Entire Course (New). Get an A++.MAT 116 Week 6 Appendix E Fueling Upquestions to answerHCA430 Discussion 1 & 2FOR A-PLUS WRITERprinciples of marketingAdvancedDQweek1Extremewrite examples

Needs help with similar assignment?

We are available 24x7 to deliver the best services and assignment ready within 3-4 hours? Order a custom-written, plagiarism-free paper

Get Answer Over WhatsApp Order Paper Now